Searching for the right software vendor, arguably one of the most important administrative decisions that a transplant center makes, can be a daunting task and every program seems to have its own approach. There are, however, some things that all centers should consider to determine which vendor and solution best fit their needs. Ability. When you’re choosing a transplant software vendor, you need to know that the...
Read More
Thanks to everyone who stopped by the EDITLife booth at the TCT 2019 Meetings in Houston! We were thrilled to connect with so many industry leaders and with the positive response to EDITLife for Cell Therapy - the patient-centric, transplant management software system that efficiently tracks and monitors BMT-specific data and supplements your EHR. And, we were inspired to work even harder to ensure that...
Read More
See EDITLife at UNOS 2019! MSA is happy to announce that we will be attending the 27th annual UNOS Transplant Management Forum (TMF) 2019, May 13-14, Loews Sapphire Falls Resort in Orlando. Plan now to stop by Booth #35. Meet up with our team of experts: Tony Fontecchio, VP, Life Sciences, and Ed Smith, Director, Business Development. See for yourself how EDITLife, a comprehensive, patient-centric, transplant...
Read MoreMSA Life Sciences, developers of the EDITLife Transplant Management System (TMS) for Cell Therapy, is pleased to be supporting the 2019 Transplantation and Cellular Therapy (TCT) Meetings. Team leaders will exhibit the state-of-the-art EDITLife clinical workflow application, February 19-23, at the Hilton Americas in Houston, TX. Something new and exciting this year: the EDITLife team will be hosting helpful educational sessions every day in Booth #2246....
Read More
Thanks to everyone who stopped by the EDITLife booth at NMDP Council Meeting 2018! The conference was a huge success again this year. We were thrilled to connect with so many industry leaders and overwhelmed by the positive response to EDITLife - the transplant management system (TMS) that streamlines the BMT process! Congratulations to the following lucky raffle winners of the Google Home Minis: Lisa Tyrrell,...
Read More
Findings presented at the American Society of Nephrology's Kidney Week 2018 suggest that gout, a risk factor for serious poor health outcomes, is much more common among solid organ transplant recipients than in the general U.S. population. Using 2016 claims data, researchers found that the prevalence of active gout was 11.3% among solid organ transplant recipients - particularly kidney and heart transplant recipients - compared...
Read More